Noëlle Callizot

For 20 years, she has enabled the pharmaceutical development of neuroactive molecules up to advanced clinical stage. During her 6 years as director of neuropharmacology at Phytopharm (UK), she has led various programs in neurodegenerative diseases (Alzheimer’s and Parkinson’s) up to phase 3.

Noëlle Callizot is the co-founder of 4 biotech companies in the fields of contract research, functional neuro-habilitation, screening and neuroactive molecules. President of the AFM-TELETHON Pharma Commission, Noëlle Callizot also chairs several strategic programs for the AFM.